AI-ENABLED MOLECULAR IMAGING
Seeing Biology In Vivo.
ImageNova Bioscience integrates AI-driven target discovery, molecular imaging, radiolabeling, tumor models, and in vivo validation to accelerate precision oncology and radiopharmaceutical development.
Leaders in Radiopharmaceutical Development
At ImageNova Bioscience, we advance therapeutic development through advanced molecular imaging. We are dedicated to delivering translational evidence by merging medicinal chemistry with pharmaceutical validation to provide data-driven insights for drug discovery.
From Molecular Signal to Translational Decision.
Our platform connects target biology, probe development, radiolabeling, in vitro evaluation, tumor models, and in vivo imaging into one integrated preclinical workflow.
Target Biology
Identify and validate disease-relevant targets to provide translational evidence for target engagement and precision oncology programs.
Probe Synthesis & Radiolabeling
Advanced probe synthesis and radiolabeling for PET/CT and radiopharmaceutical development, ensuring optimal PK/PD and biomarker accuracy.
In Vivo Molecular Imaging
Quantitative in vivo molecular imaging to track biodistribution and validate tumor models with measurable translational evidence.
An Integrated Platform from Target to Evidence.
ImageNova turns biological hypotheses into measurable in vivo evidence through an integrated molecular imaging and radiopharmaceutical development workflow.
Target Discovery → Bio-Ligand Design → Probe Synthesis & Radiolabeling → In Vitro Evaluation → Tumor Models → Molecular Imaging Validation → Translational Decision •
Inquire Now
Contact our scientific lead at info@imagenova.us or reach 1-408-588-1998 to discuss strategic pharmaceutical partnerships.
Inquiries
info@imagenova.us
Office
2245C Fortune Drive, San Jose, CA 95131
Radiopharmaceutical R&D and Molecular Analysis
Access our integrated development platform for drug validation and tracer optimization.
